As per this study the Global Structural Heart Devices Market was valued USD 14.46 BN (by revenue) in 2022 and is anticipated to reach USD 33.81 BN by 2030 with a CAGR of 11.2%.
Structural heart devices or solutions are used to treat a broad range of structural heart disease which includes both congenital heart defects and acquired conditions. Transcatheter valvular solutions, surgical valvular solutions, and structural heart occluders are some of the devices which are commonly used for the optimal treatment of the patients.
Market Dynamics
The structural heart devices represent the highest demand owing to the fastest growing cardiovascular disease among people. With the largest structural heart devices portfolio along with the advancement in the product pipeline through new technologies is also expected to foster the market growth. However, the high cost of the surgeries is likely to curb market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of structural heart devices.
Market Segmentation
The broad structural heart devices market has been sub-grouped into type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product
- Herat Valve Devices
- Surgical Heart Valves
- Transcatheter Heart Valves
- Occluders and Delivery Systems
- Annuloplasty Rings
- Other Devices
- Accessories
By Procedure
- Replacement Procedures
- TAVR Procedures
- SAVR Procedures
- Repair Procedures
- Closure Procedures
- Annuloplasty
- Valvuloplasty
- TMVR Procedures
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for structural heart devices in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Structural Heart Devices Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the structural heart devices market include Edwards Lifesciences Corporation (US), Mectronic pic (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova PLC (UK), CryoLife, Inc. (US), Micro Interventional Devices, Inc. (US), Bralie Biomédica (Brazil), Lepu Medical Technology (Beijing) Co. Ltd. (China), and TTK Healthcare Limited (India). An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.